Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON.
| Revenue (Most Recent Fiscal Year) | $5.10B |
| Net Income (Most Recent Fiscal Year) | $-360.00M |
| PE Ratio (Current Year Earnings Estimate) | 22.35 |
| PE Ratio (Trailing 12 Months) | 24.38 |
| PEG Ratio (Long Term Growth Estimate) | 0.57 |
| Price to Sales Ratio (Trailing 12 Months) | 1.21 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.00 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.81 |
| Pre-Tax Margin (Trailing 12 Months) | -1.22% |
| Net Margin (Trailing 12 Months) | -3.21% |
| Return on Equity (Trailing 12 Months) | 4.14% |
| Return on Assets (Trailing 12 Months) | 1.93% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.55 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.02 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.79 |
| Inventory Turnover (Trailing 12 Months) | 2.08 |
| Book Value per Share (Most Recent Fiscal Quarter) | $18.40 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.16 |
| Earnings per Share (Most Recent Fiscal Year) | $0.43 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.48 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 357.17M |
| Free Float | 351.99M |
| Market Capitalization | $6.44B |
| Average Volume (Last 20 Days) | 0.40M |
| Beta (Past 60 Months) | 0.56 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.45% |
| Percentage Held By Institutions (Latest 13F Reports) | 11.07% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |